Table 2:
Total (n = 136) | Good Outcome (n = 29) | Poor Outcome (n = 107) | P Valuea | |
---|---|---|---|---|
Age (mean) (SD) | 80.6 (10.1) | 79.5 (13.2) | 81.0 (9.2) | .585 |
Female (No.) (%) | 90 (66.2) | 20 (69.0) | 70 (65.4) | .827 |
Diabetes (No.) (%) | 34 (25.0) | 5 (17.2) | 29 (27.1) | .340 |
Hypertension (No.) (%) | 102 (75.0) | 21 (72.4) | 81 (75.7) | .809 |
Arrhythmia (No.) (%) | 84 (61.8) | 19 (65.5) | 65 (60.7) | .674 |
Coronary heart disease (No.) (%) | 41 (30.1) | 8 (27.6) | 33 (30.8) | .822 |
Hypercholesterolemia (No.) (%) | 41 (30.1) | 8 (27.6) | 33 (30.8) | .822 |
Premorbid mRS (No.) (%) | .719 | |||
3 | 111 (81.6) | 23 (79.3) | 88 (82.2) | |
4 | 25 (18.4) | 6 (20.7) | 19 (17.8) | |
Baseline NIHSS (median) (IQR) | 18 (15–22) | 15 (12–19) | 19 (15–23) | .009 |
ASPECTS (median) (IQR) | 9 (8–10) | 10 (9–10) | 9 (8–10) | .051 |
Intravenous thrombolysis (No.) (%) | 61 (44.9) | 13 (44.8) | 48 (44.9) | 1.000 |
Onset-to-groin (median) (IQR) | 240 (180–344) | 232 (182–280) | 247 (180–357) | .250 |
Groin-to-TICI (median) (IQR) | 75 (41–108) | 63 (32–97) | 77 (46–117) | .142 |
Occlusion site (No.) (%) | ||||
ICA | 31 (22.8) | 2 (6.9) | 29 (27.1) | .024 |
M1 | 78 (57.4) | 15 (51.7) | 63 (58.9) | .530 |
M2 | 30 (22.1) | 12 (41.4) | 18 (16.8) | .010 |
TICI 2b–3 | 103 (75.7) | 27 (93.1) | 76 (71.0) | .014 |
Note:—IQR indicates interquartile range.
Comparison between patients with good and poor outcomes.